PMCB Forecast — Price Prediction for 2025. Should I Buy PMCB?
1-Day-Price-Prediction
-2.38%
1-Week Prediction
+7.4%
1-Month Prediction
+12.7%
2026 Prediction
-0.49%
2030 Prediction
+42.5%
Based on our advanced algorithm, we predict that PMCB stock price will experience significant movement in the coming periods. Our 1-day prediction estimates a price of $0.93, while the 1-week outlook suggests a value of $1.02. For the 1-month forecast, we project a price of $1.07. Looking further ahead, our 2026 projection estimates a value of $0.95, with a long-term 2030 forecast reaching $1.35. Stay informed and make strategic decisions with our data-driven insights!
Should I Buy PharmaCyte Biotech Inc Stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. PMCB has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
PMCB stock price ended at $0.95 on Tuesday, after rising0.85%
The PharmaCyte Biotech Inc stock price increased by 0.85% on the last trading day (16 Dec 2025), rising from 0.91 to 0.95. Throughout the last trading session, the stock experienced a fluctuation of 17.24% , ranging from a day low of $0.8188 to a day high of 0.96. The price has declined in 5 of the last 10 days, resulting in a total change of 27.16% during this period. On the last day, trading volume decrease by 230.28K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 547.76K shares were traded, amounting to approximately 486.45K.
PMCB Technical Signals
PMCB(PharmaCyte Biotech Inc Corp) has 3 buy signals and 1 sell signal now. The current trend is a downtrend starting from 2025-12-05. The total price change during this trend is -22.13%. Recently, the price has increased significantly while volume increased, indicating a strong bullish signal. The average turnover of PMCB over the last 5 trading days is 978.58K. Overall, the technical indicator signals lean more toward a Bullish outlook in the mid-term.
PMCB Moving Average Analysis
PharmaCyte Biotech Inc's overall moving average trend leans more bearish as of Wednesday, December 17, 2025, with 3 negative signals and 1 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $1.58, and $1.87. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $0.61, and $0.31. A break-down below any of these levels will issue sell signals.
PMCB Short Selling Analysis
The short sale ratio of PharmaCyte Biotech Inc(PMCB) as of 10 Dec 2025 is 13.08%, dropping from last trading day. With decreasing price from 1.11 to 1.04. The short sell activity indicate that short sellers may be anticipating price hit a bottom.
Technical Signal
Technical Signals Summary
Sell
1
Buy
3
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Positive
SMA_5 Above SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
3 Bullish Signals
3 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 > 0
0.0961
Bullish
Momentum (10 days)
MOM_10 > 0
0.203
Bullish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
0.0423
Bullish
1 Bearish Signals
1 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Indicators
Signal
Value
Meaning
Moving Average
5-day SMA crosses below 10-day SMA
--
Bearish
PMCB Stock Forecast
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
Month
Min. Price
Avg. Price
Max. Price
Potential ROI
Jan 2026
$0.92
$0.94
$1.01
-8.73%
Feb 2026
$0.77
$0.94
$0.96
-9.13%
Mar 2026
$1.12
$1.13
$1.13
+9.77%
Apr 2026
$0.83
$0.94
$1.10
-8.91%
May 2026
$0.96
$1.03
$1.11
+0.31%
Jun 2026
$0.83
$0.98
$1.09
-4.89%
Jul 2026
$1.16
$1.21
$1.28
+17.01%
Aug 2026
$0.85
$0.98
$1.15
-4.86%
Sep 2026
$0.86
$0.92
$1.01
-10.75%
Oct 2026
$0.94
$1.12
$1.19
+8.50%
Nov 2026
$1.07
$1.07
$1.11
+4.07%
Dec 2026
$0.86
$0.95
$0.97
-8.22%
In 2026, PharmaCyte Biotech Inc (PMCB) is anticipated to change hands in a trading channel between $0.77 and $1.28.
PharmaCyte Biotech Inc Stock Forecast 2026
Jan 2026: PMCB Stock Forecast
Potential ROI: -8.73%
In Jan 2026, PharmaCyte Biotech Inc's value is forecasted to reach an average price of $0.94. The price is predicted to fluctuate between a low of $0.92 and a high of $1.01.
Feb 2026: PMCB Stock Forecast
Potential ROI: -9.13%
In Feb 2026, PharmaCyte Biotech Inc's value is forecasted to reach an average price of $0.94. The price is predicted to fluctuate between a low of $0.77 and a high of $0.96.
Mar 2026: PMCB Stock Forecast
Potential ROI: 9.77%
In Mar 2026, PharmaCyte Biotech Inc's value is forecasted to reach an average price of $1.13. The price is predicted to fluctuate between a low of $1.12 and a high of $1.13.
Apr 2026: PMCB Stock Forecast
Potential ROI: -8.91%
In Apr 2026, PharmaCyte Biotech Inc's value is forecasted to reach an average price of $0.94. The price is predicted to fluctuate between a low of $0.83 and a high of $1.10.
May 2026: PMCB Stock Forecast
Potential ROI: 0.31%
In May 2026, PharmaCyte Biotech Inc's value is forecasted to reach an average price of $1.03. The price is predicted to fluctuate between a low of $0.96 and a high of $1.11.
Jun 2026: PMCB Stock Forecast
Potential ROI: -4.89%
In Jun 2026, PharmaCyte Biotech Inc's value is forecasted to reach an average price of $0.98. The price is predicted to fluctuate between a low of $0.83 and a high of $1.09.
Jul 2026: PMCB Stock Forecast
Potential ROI: 17.01%
In Jul 2026, PharmaCyte Biotech Inc's value is forecasted to reach an average price of $1.21. The price is predicted to fluctuate between a low of $1.16 and a high of $1.28.
Aug 2026: PMCB Stock Forecast
Potential ROI: -4.86%
In Aug 2026, PharmaCyte Biotech Inc's value is forecasted to reach an average price of $0.98. The price is predicted to fluctuate between a low of $0.85 and a high of $1.15.
Sep 2026: PMCB Stock Forecast
Potential ROI: -10.75%
In Sep 2026, PharmaCyte Biotech Inc's value is forecasted to reach an average price of $0.92. The price is predicted to fluctuate between a low of $0.86 and a high of $1.01.
Oct 2026: PMCB Stock Forecast
Potential ROI: 8.50%
In Oct 2026, PharmaCyte Biotech Inc's value is forecasted to reach an average price of $1.12. The price is predicted to fluctuate between a low of $0.94 and a high of $1.19.
Nov 2026: PMCB Stock Forecast
Potential ROI: 4.07%
In Nov 2026, PharmaCyte Biotech Inc's value is forecasted to reach an average price of $1.07. The price is predicted to fluctuate between a low of $1.07 and a high of $1.11.
Dec 2026: PMCB Stock Forecast
Potential ROI: -8.22%
In Dec 2026, PharmaCyte Biotech Inc's value is forecasted to reach an average price of $0.95. The price is predicted to fluctuate between a low of $0.86 and a high of $0.97.
PMCB Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to PharmaCyte Biotech Inc(PMCB), our algorithm predicts PMCB's 1-month price at $1.06, with an 3.47%upwardshift. Using a similarity score up to 95.76%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for PharmaCyte Biotech Inc (PMCB.O) stock, as of Sunday, December 14, 2025 , forecasts a 3.47% change over the next month, based on its high correlation with TTMI.O stock patterns. The similarity between their price movements over the analyzed periods is 95.76%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
PMCB
No data
TTMI
Up: 3.47%Similarity: 95.76%
Name
Similarity
Up/Down
TTMI.O
95.76%
+3.47%
SMC.N
95.53%
+29.75%
SXC.N
94.79%
-14.49%
MAXN.O
94.73%
+17.80%
BNGO.O
94.72%
-9.50%
VSA.O
94.57%
+90.07%
GILT.O
94.57%
-8.08%
LOPE.O
94.40%
+7.67%
UFI.N
94.32%
-1.63%
LBTYB.O
94.23%
+11.53%
PMCB Seasonality Analysis
Based on PMCB's historical stock price data across all years, the probability of a positive return in December is45.45%, suggesting it maynotbe an ideal month to invest in PMCB. In contrast,Januaryoffers the highest probability of positive returns at66.67%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying PharmaCyte Biotech Inc (PMCB.O) stock in January has the highest probability of a positive return (66.67%), while August has the lowest probability (9.09%).
Performance Seasonality
The chart shows PharmaCyte Biotech Inc. (PMCB)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
Should I buy PharmaCyte Biotech Inc (PMCB.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. PMCB has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
Which months have the highest win rate for buying PharmaCyte Biotech Inc (PMCB.O) stock in a year?
The radar chart shows that buying PharmaCyte Biotech Inc (PMCB.O) stock in January has the highest probability of a positive return (66.67%), while August has the lowest probability (9.09%).
How has PharmaCyte Biotech Inc. (PMCB)'s stock price performed over the past three years?
PMCB's stock price fell by -26.28% in 2023,decreased by -28.15% in 2024, and went down by 42.08%in 2025.
Bearish technical signals of PMCB include: 5-day SMA crosses below 10-day SMA.
Is PMCB a buy based on overall technical signals summary?
PMCB has 3 buy signals and 1 sell signals now. Overall the technical rating for PMCB is Buy . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of PMCB.
What is the trend of PharmaCyte Biotech Inc (PMCB)'s moving average?
PharmaCyte Biotech Inc's overall moving average trend leans more bearish as of December 17 2025, with 3 negative signals and 1 positive signal.
What is price prediction for PMCB stock next month?
The price prediction chart for PharmaCyte Biotech Inc (PMCB.O) stock, as of December 14 2025, forecasts a 3.47% change over the next month, based on its high correlation with TTMI stock patterns. The similarity between their price movements over the analyzed periods is 95.76%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2026 for PharmaCyte Biotech Inc (PMCB) Stock?
In Dec 2026, PharmaCyte Biotech Inc's value is forecasted to reach an average price of $0.95. The price is predicted to fluctuate between a low of $0.86 and a high of $0.97.
What is price prediction 2030 for PharmaCyte Biotech Inc (PMCB) Stock?
In Dec 2030, PharmaCyte Biotech Inc's value is forecasted to reach an average price of $1.35. The price is predicted to fluctuate between a low of $1.16 and a high of $1.47.
Negative
Positive
